Skip to main content
. Author manuscript; available in PMC: 2016 Aug 15.
Published in final edited form as: J Immunol. 2015 Jul 15;195(4):1774–1781. doi: 10.4049/jimmunol.1500522

Figure 1. Phenotying of blood monocyte and DC subsets in humans (A) and rhesus macaques (B).

Figure 1

EDTA-treated blood samples were stained with antibodies shown in Table 1 and analyzed by 11-color flow cytometry. (A) In HLA-DR+CD3CD20CD56 populations, human monocyte and DC subsets were gated and divided into 4 populations by CD14 and CD16 expression as follows; (a) CD14+CD16 monocytes, (b) CD14+CD16+ monocytes, (c) CD14CD16+ monocytes, and a CD14CD16 population that was further divided into (d) CD123+ pDC and (e) BDCA-1+ mDC. In addition, a CD141+ mDC (f) was identified. (B) To analyze rhesus monocyte and DC subsets, HLA-DR+CD3CD20CD8cell populations were similarly gated and further divided as described in panel A with the exception that antibody to human CD141 (BDCA-3) did not cross-react to, or detect this marker on rhesus macaque cells. The populations of cells identified included; (a) CD14+CD16 monocytes, (b) CD14+CD16+ monocytes, (c) CD14CD16+ monocytes, (d) CD123+ pDC, and (e) BDCA-1+ mDC.